Influence of 5,10-methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease
- 31 August 1999
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 34 (2) , 259-263
- https://doi.org/10.1016/s0272-6386(99)70353-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Major determinants of hyperhomocysteinemia in peritoneal dialysis patientsKidney International, 1998
- A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarctionAtherosclerosis, 1997
- Membrane protein damage and methylation reactions in chronic renal failureKidney International, 1996
- A common mutation in methylenetetrahydrofolate reductase gene among the Japanese populationJournal of Human Genetics, 1996
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine ConcentrationsCirculation, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular diseaseMetabolism, 1988
- Current trends in the estimation of Michaelis-Menten parametersAnalytical Biochemistry, 1980
- Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine‐homocysteine mixed disulphideEuropean Journal of Clinical Investigation, 1979